Pfizer Inc. will sell its COVID-19 vaccines at a 10,000 percent markup in 2023 following record-breaking profits in 2022.
Quartz reports:
“The company announced on Oct. 20 that it intends to sell the covid vaccine, marketed under the brand name Comirnaty, for $110 to $130 per dose.
This is about four times the current selling price—and 100 times the estimated cost of manufacturing the vaccine.
According to The People's Vaccine Alliance, a coalition of over 100 organizations working to end vaccine inequity, Pfizer spends less than $1.20 to produce each dose of vaccine. This estimate was drawn from an analysis conducted by international nonprofit Oxfam, based on data from consumer advocacy Public Citizen and the Imperial College, London.
Pfizer has not challenged the estimate, which would imply that the 2023 price represents a 10,000% markup over the manufacturing cost.
